The long‐acting β2‐adrenoceptor agonist olodaterol attenuates pulmonary inflammation

E-ISSN： 1476-5381|172|14|3537-3547

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.14, 2015-07, pp. : 3537-3547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The long‐acting β2‐adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor‐mediated transcription in human airway epithelial cells in a gene‐ and agonist‐dependent manner

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 10, 2015-05 ,pp. : 2634-2653

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of chronic treatment with the new ultra‐long‐acting β2‐adrenoceptor agonist indacaterol alone or in combination with the β1‐adrenoceptor blocker metoprolol on cardiac remodelling

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3627-3637

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe

International Archives of Allergy and Immunology, Vol. 157, Iss. 3, 2011-11 ,pp. : 303-310

Karger

Access to resources Recommend Favorite

Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite